Publications by authors named "A Boeker"
Objective: We prospectively addressed whether patient characteristics, oncological outcomes, or metastatic risk impacted depression and anxiety in patients undergoing curative proton treatment for uveal melanoma (UM).
Methods: We assessed patient-reported outcomes regarding anxiety (GAD-7) before and 2 years after proton therapy and depression (PHQ-9) before, 1, and 2 years after proton therapy. We performed descriptive statistics and used linear mixed effect modeling to analyze how the oncological outcome and baseline characteristics impacted anxiety and depression scores.
Benchmarking calf health: Assessment tools for dairy herd health consultancy based on reference values from 730 German dairies with respect to seasonal, farm type, and herd size effects.
Front Vet Sci
September 2022
Good calf health is crucial for a successfully operating farm business and animal welfare on dairy farms. To evaluate calf health on farms and to identify potential problem areas, benchmarking tools can be used by farmers, herd managers, veterinarians, and other advisory persons in the field. However, for calves, benchmarking tools are not yet widely established in practice.
View Article and Find Full Text PDFArticle Synopsis
- Cytogenetic testing (CGT) helps uveal melanoma patients understand their risk of cancer spreading, but there's no treatment that can change the results, making it just information.
- In a study, 121 patients answered questions about their interest in CGT, with 43% not interested, 28.1% unsure, and 28.9% wanting to know.
- Many patients felt stressed about the decision and were influenced by their doctors and online information, especially worrying that knowing their test results could change their lives.
Ab interno canaloplasty (ABiC)-12-month results of a new minimally invasive glaucoma surgery (MIGS).
Graefes Arch Clin Exp Ophthalmol
September 2019
Purpose: The aim of this study is to assess whether the ab interno canaloplasty is a reasonable minimally invasive method to lower significantly the IOP level and number of antiglaucomatous medication over a certain period of time in adult primary open angle glaucoma (POAG).
Methods: In this retrospective cohort outcome study, 36 eyes of 28 POAG patients (mean age 74.8 ± 9.